Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Germain Jelin

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
La Revue Du Praticien|July 14, 2015
[Arthrosis]Nassima Dehamchia-Rehailia, Germain Jelin, Patrice Fardellone, et al.
Internal Medicine Journal|February 21, 2022
Polyarticular septic arthritis caused by Erysipelothrix rhusiopathiae infectionJulia Goossens, Marine Forien, Germain Jelin, et al.
Joint Bone Spine|October 7, 2018
Antisynthetase syndrome and cardiac involvement: a rare associationLoïc Meudec, Germain Jelin, Marine Forien, et al.
Internal Medicine Journal|December 23, 2021
Whipple disease mimicking polymyalgia rheumatica with initial response to tocilizumabLoic Meudec, Germain Jelin, Julia Goossens, et al.
International Journal of Rheumatic Diseases|February 1, 2022
Horner syndrome after cervical spine corticosteroid injectionNolan Hassold, Laura Pina Vegas, Germain Jelin, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|May 17, 2021
Groin Pain After Gemcitabine for Lung CancerLaura Pina Vegas, Germain Jelin, Elisabeth Palazzo, et al.
Internal Medicine Journal|June 22, 2021
Systemic sclerosis-associated interstitial lung disease treated with tocilizumabVincent Dauny, Raphael Borie, Marine Forien, et al.
JAAD Case Reports|February 9, 2019
Bowel-associated dermatosis arthritis syndrome: A case report with first positron emission tomography analysisNolan Hassold, Germain Jelin, Elisabeth Palazzo, et al.
Pharmacology|April 27, 2016
Decrease of Tocilizumab Dose in Patients with Rheumatoid Arthritis: A Pilot StudyMarie Fechtenbaum, Pauline Lasselin-Boyard, Sarah Salomon, et al.
Clinical Rheumatology|March 4, 2017
Are abatacept and tocilizumab intravenous users willing to switch for the subcutaneous route of administration? A questionnaire-based studyMarie Desplats, Tristan Pascart, Germain Jelin, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
La Revue Du Praticien|July 14, 2015
[Arthrosis]Nassima Dehamchia-Rehailia, Germain Jelin, Patrice Fardellone, et al.
Internal Medicine Journal|February 21, 2022
Polyarticular septic arthritis caused by Erysipelothrix rhusiopathiae infectionJulia Goossens, Marine Forien, Germain Jelin, et al.
Joint Bone Spine|October 7, 2018
Antisynthetase syndrome and cardiac involvement: a rare associationLoïc Meudec, Germain Jelin, Marine Forien, et al.
Internal Medicine Journal|December 23, 2021
Whipple disease mimicking polymyalgia rheumatica with initial response to tocilizumabLoic Meudec, Germain Jelin, Julia Goossens, et al.
International Journal of Rheumatic Diseases|February 1, 2022
Horner syndrome after cervical spine corticosteroid injectionNolan Hassold, Laura Pina Vegas, Germain Jelin, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|May 17, 2021
Groin Pain After Gemcitabine for Lung CancerLaura Pina Vegas, Germain Jelin, Elisabeth Palazzo, et al.
Internal Medicine Journal|June 22, 2021
Systemic sclerosis-associated interstitial lung disease treated with tocilizumabVincent Dauny, Raphael Borie, Marine Forien, et al.
JAAD Case Reports|February 9, 2019
Bowel-associated dermatosis arthritis syndrome: A case report with first positron emission tomography analysisNolan Hassold, Germain Jelin, Elisabeth Palazzo, et al.
Pharmacology|April 27, 2016
Decrease of Tocilizumab Dose in Patients with Rheumatoid Arthritis: A Pilot StudyMarie Fechtenbaum, Pauline Lasselin-Boyard, Sarah Salomon, et al.
Clinical Rheumatology|March 4, 2017
Are abatacept and tocilizumab intravenous users willing to switch for the subcutaneous route of administration? A questionnaire-based studyMarie Desplats, Tristan Pascart, Germain Jelin, et al.
Pageof 2